The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Feasibility of Outpatient Fully Integrated Closed-Loop Control
Open accessAbstract
OBJECTIVE: To evaluate the feasibility of a wearable artificial pancreas system, the Diabetes Assistant (DiAs), which uses a smart phone as a closed-loop control platform. RESEARCH DESIGN AND METHODS: Twenty patients with type 1 diabetes were enrolled at the Universities of Padova, Montpellier, and Virginia and at Sansum Diabetes Research Institute. Each trial continued for 42 h. The United States studies were conducted entirely in outpatient setting (e.g., hotel or guest house); studies in Italy and France were hybrid hospital–hotel admissions. A continuous glucose monitoring/pump system (Dexcom Seven Plus/Omnipod) was placed on the subject and was connected to DiAs. The patient operated the system via the DiAs user interface in open-loop mode (first 14 h of study), switching to closed-loop for the remaining 28 h. Study personnel monitored remotely via 3G or WiFi connection to DiAs and were available on site for assistance. RESULTS: The total duration of proper system communication functioning was 807.5 h (274 h in open-loop and 533.5 h in closed-loop), which represented 97.7% of the total possible time from admission to discharge. This exceeded the predetermined primary end point of 80% system functionality. CONCLUSIONS: This study demonstrated that a contemporary smart phone is capable of running outpatient closed-loop control and introduced a prototype system (DiAs) for further investigation. Following this proof of concept, future steps should include equipping insulin pumps and sensors with wireless capabilities, as well as studies focusing on control efficacy and patient-oriented clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetes: Models, Signals, and Control
Cobelli, C., Dalla Man, C., Sparacino, G., Magni, L., De Nicolao, G., & Kovatchev, B. P. (2009) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2009.2036073 · Cited by 511
Self-citationKovatchev, B., Cobelli, C., Renard, E., Anderson, S., Breton, M., Patek, S., Clarke, W., Bruttomesso, D., Maran, A., Costa, S., et al. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400611 · Cited by 200
Self-citation
Research works printed but not linked: 19
- Pickup, 1978, Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia, BMJ, 1, 204, 10.1136/bmj.1.6107.204 · DOI · Paper page
- Tamborlane, 1979, Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump, N Engl J Med, 300, 573, 10.1056/NEJM197903153001101 · DOI · Paper page
- Mastrototaro, 2000, The MiniMed continuous glucose monitoring system, Diabetes Technol Ther, 2, S13, 10.1089/15209150050214078 · DOI · Paper page
- Bode, 2000, Clinical utility of the continuous glucose monitoring system, Diabetes Technol Ther, 2, S35, 10.1089/15209150050214104 · DOI
- Bellazzi, 2001, The subcutaneous route to insulin-dependent diabetes therapy: closed-loop and partially closed-loop control strategies for insulin delivery and measuring glucose concentration, IEEE Eng Med Biol, 20, 54, 10.1109/51.897828 · DOI
- Hovorka, 2004, Closing the loop: the adicol experience, Diabetes Technol Ther, 6, 307, 10.1089/152091504774197990 · DOI
- Steil, 2006, Feasibility of automating insulin delivery for the treatment of type 1 diabetes, Diabetes, 55, 3344, 10.2337/db06-0419 · DOI · Paper page
- Weinzimer, 2008, Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas, Diabetes Care, 31, 934, 10.2337/dc07-1967 · DOI · Paper page
- Hovorka, 2010, Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial, Lancet, 375, 743, 10.1016/S0140-6736(09)61998-X · DOI · Paper page
- El-Khatib, 2010, A bihormonal closed-loop artificial pancreas for type 1 diabetes, Sci Transl Med, 2, 27ra27, 10.1126/scitranslmed.3000619 · DOI · Paper page
- Breton, 2012, Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia, Diabetes, 61, 2230, 10.2337/db11-1445 · DOI · Paper page
- Cobelli, 2011, Artificial pancreas: past, present, future, Diabetes, 60, 2672, 10.2337/db11-0654 · DOI · Paper page
- Kovatchev, 2009, Control to range for diabetes: functionality and modular architecture, J Diabetes Sci Tech, 3, 1058, 10.1177/193229680900300509 · DOI
- Kovatchev, 2009, In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes, J Diabetes Sci Tech, 3, 44, 10.1177/193229680900300106 · DOI · Paper page
- O’Grady, 2012, The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes, Diabetes Care, 35, 2182, 10.2337/dc12-0761 · DOI
- Cobelli, 2012, Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes, Diabetes Care, 35, e65, 10.2337/dc12-0660 · DOI
- Hughes, 2010, Hypoglycemia prevention via pump attenuation and red-yellow-green “traffic” lights using continuous glucose monitoring and insulin pump data, J Diabetes Sci Tech, 4, 1146, 10.1177/193229681000400513 · DOI
- Patek, 2012, DelFaverok S, Breton M, Dalla Man C, Renard E, Zisser H, Doyle FJ III, Cobelli C, Kovatchev BP. Modular closed-loop control of diabetes, Trans Biomed Engineer, 29, 2986, 10.1109/TBME.2012.2192930 · DOI · Paper page
- Beck, 2013, Challenges for outpatient closed loop studies: how to assess efficacy, Diabetes Technol Ther, 15, 1, 10.1089/dia.2012.0289 · DOI
Cited by
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., Balliro, C., Hillard, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 602
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Self-citationHome Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Smart wearable body sensors for patient self-assessment and monitoring
Appelboom, G., Camacho, E., Abraham, M. E., Bruce, S. S., Dumont, E. L., Zacharia, B. E., D’Amico, R., Slomian, J., Reginster, J. Y., Bruyère, O., et al. (2014) · Archives of Public Health · doi:10.1186/2049-3258-72-28 · Cited by 448
Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms
Doyle, F. J., Huyett, L. M., Lee, J. B., Zisser, H. C., & Dassau, E. (2014) · Diabetes Care · doi:10.2337/dc13-2108 · Cited by 394
Self-citation
Metadata
- Authors
- Kovatchev, B. P., Renard, E., Cobelli, C., Zisser, H. C., Keith-Hynes, P., Anderson, S. M., Brown, S. A., Chernavvsky, D. R., Breton, M. D., Farret, A., Pelletier, M.-J., Place, J., Bruttomesso, D., Del Favero, S., Visentin, R., Filippi, A., Scotton, R., Avogaro, A., & Doyle, F. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-06-12
- Volume
- 36
- Issue
- 7
- Pages
- 1851-1858
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2029069327
- Cited by
- 177
- References
- 2
- FWCI
- 23.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Feasibility of Outpatient Fully Integrated Closed-Loop Control. https://app.cochat.ai/papers/10.2337/dc12-1965
- The paper
- Kovatchev, B. P., Renard, E., Cobelli, C., Zisser, H. C., Keith-Hynes, P., Anderson, S. M., Brown, S. A., Chernavvsky, D. R., Breton, M. D., Farret, A., Pelletier, M.-J., Place, J., Bruttomesso, D., Del Favero, S., Visentin, R., Filippi, A., Scotton, R., Avogaro, A., & Doyle, F. J. (2013). Feasibility of Outpatient Fully Integrated Closed-Loop Control. Diabetes Care. https://doi.org/10.2337/dc12-1965
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.